The agency is also examining allegations that Twisha Sharma may have been assaulted before her death and whether any evidence ...

Cars have become dramatically safer over the past few decades, but according to new research from the Graz University of Technology, women still aren’t benefiting equally from those advances. The ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

Somewhere over the Indian Ocean, if everything goes right, two small camera probes will separate from a Starship upper stage ...

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva’s goal is to transform the lives of patients with ...

ADEX has published a first-hand investigation into an active XCSSET malware infection targeting macOS developer pipelines, ...

Both patients with asthma who switched from mepolizumab/benralizumab to depemokimab and patients who continued ...

The Board clarified that the allegedly compromised portal contained only sample data used for internal testing, while the ...

New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without showing signs of the dangerous virus.

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers reported Thursday.

Discusses Product Innovation With Headless 360 and Slackbot May 29, 2026 2:00 PM EDTCompany ParticipantsValmik Desai - ...

Reliance Jio has launched a new affordable Jio OTT Pass priced at ₹200, aiming to bundle entertainment and connectivity into a single offering. The pack includes access to premium OTT platforms, live ...